BridgeMD
New treatment option for Alcohol-related Liver Disease
Official title Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
ClinicalTrials.gov ID: NCT06269510
What this study is testing
- What it's testing
- The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Willingness to comply with all study procedures and availability for the duration of the study
- Willing and able to provide informed consent
- Enrolled at University of Michigan (UM) hepatology clinics or inpatients at UM Hospitals
- Documented diagnosis of alcohol-related liver disease (ALD) (per protocol)
- Recent alcohol use of any amount within the past 6 months as assessed by either patient interview, medical chart review, or positive alcohol...
You likely can't join if
- Unable to provide voluntary informed consent for any reason
- Substantially cognitively impaired as evidenced by Westhaven grade 2 or higher hepatic encephalopathy or a score \>=10 on the Short Blessed Test for...
- Unable to read or understand English
- Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation
- Is enrolled in the multidisciplinary ALD clinic at Michigan Medicine
- Any other medical condition or circumstance that precludes safe and meaningful participation in the study
See the full eligibility criteria
- Willingness to comply with all study procedures and availability for the duration of the study
- Willing and able to provide informed consent
- Enrolled at University of Michigan (UM) hepatology clinics or inpatients at UM Hospitals
- Documented diagnosis of alcohol-related liver disease (ALD) (per protocol)
- Recent alcohol use of any amount within the past 6 months as assessed by either patient interview, medical chart review, or positive alcohol biomarker (e.g. blood alcohol level, urinary ethyl glucuronide, urinary ethyl...
- No alcohol use treatment within the past 1 month including, but not limited to:
- Any professionally lead therapy with a mental health counselor (such as, one-on-one therapy, group therapy, couples or family therapy) with a primary aim of alcohol abstinence or reduction in alcohol use.
- Community-based alcohol recovery groups (such as, Alcoholics Anonymous, SMART Recovery, Celebrate Recovery, Refuge Recovery)
- Community-based church support groups primarily focused on alcohol abstinence or reduction in use.
- Residential (inpatient) alcohol treatment
- Intensive outpatient programs
- Any telehealth version of the above options
- Access to a Smartphone or computer for purposes of follow-up. Those who do not have a Smartphone will be provided one along with a calling/data plan at no cost to subject by the study team for the duration of the...
- Ability to speak and comprehend English
- Unable to provide voluntary informed consent for any reason
- Substantially cognitively impaired as evidenced by Westhaven grade 2 or higher hepatic encephalopathy or a score \>=10 on the Short Blessed Test for cognitive impairment.
- Unable to read or understand English
- Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation
- Is enrolled in the multidisciplinary ALD clinic at Michigan Medicine
- Any other medical condition or circumstance that precludes safe and meaningful participation in the study
- History of nonadherence to previous clinical or research studies
The study team makes the final eligibility decision.
Where it's taking place
- Detroit, Michigan, United States
Compensation & support
Some study costs may be covered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Detroit, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.